Blue Owl Q3 Shows Fee Growth But Liquidity Question Lingers

What happened

Blue Owl reported Q3 2026 fee-related earnings of $0.27 and distributable earnings of $0.24, up 15% and 14% respectively over the prior twelve months. These results extend the firm's consistent fee-driven earnings growth, with management fees continuing to dominate over performance revenue. However, the earnings release did not provide updated tender request data for OCIC/OTIC, the key metric that has pressured the stock. The master report's thesis hinged on a decline in tender intensity by Q3 2026 to validate the 'headline-driven spike' narrative. Without that data, investors cannot confirm whether retail liquidity stress is easing, leaving the WAIT rating intact.

Implication

Over the next 3-6 months, monitor OCIC/OTIC tender requests and any changes to liquidity terms. If tenders fall below 15%/25% as outlined in the master report, the stock could re-rate toward $11.50-$15.50. If tenders remain elevated or gates appear, the equity may fall toward $7.00. The current earnings strength provides margin support but does not resolve the core liquidity overhang.

Thesis delta

Blue Owl's Q3 earnings confirm the fee machine remains intact, with FRE and DE growing double digits. However, this does not address the central thesis question of whether retail tender pressure is normalizing. The delta is modestly positive on earnings durability but neutral on liquidity, so the WAIT rating and $10.10 reference price remain appropriate pending disclosure.